About the Webinar

The baculovirus and insect cell expression system is experiencing a resurgence as a highly effective and versatile platform for producing recombinant proteins, AAVs, and vaccines. In this webinar, you will discover key strategies for harnessing the robust power of the insect cell manufacturing platform in structural biology and gene therapy applications to enable high-yield, cost-effective production. In addition, you will gain new insights into the scalability of the platform using Thomson growth flasks to streamline production from small-scale to large-scale manufacturing.

Guest Speaker

Dr. Thera Mulvania

Dr. Thera Mulvania, President of Expression Systems, an Advancion company, has dedicated her entire academic and professional career to developing a deep expertise in the field of cell culture applications. She received her bachelor's degree in biological sciences and a Ph.D. in microbiology and immunology from the University of California, Davis. In 2002, Dr. Mulvania joined Expression Systems as Principal Scientist and later became co-owner and Chief Operating Officer until it was acquired by Advancion Corporation in November 2022.

What You'll Learn

• Overview of Expression Systems technology platform: Insect cells, media, and services

• Relevant applications including GPCR proteins and Adeno-Associated Virus (AAV)

• Methods to make a recombinant baculovirus

• Protein production optimization strategies

• Scale up process using Thomson flasks